Sort   by:  
 Page size 
UnknownBamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Not available
S-EPMC8314785 | biostudies-literature
UnknownThe contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials.
Not available
S-EPMC9322426 | biostudies-literature
UnknownPatients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.
Not available
S-EPMC11333651 | biostudies-literature
Unknownβ Cell GLP-1R Signaling Alters α Cell Proglucagon Processing after Vertical Sleeve Gastrectomy in Mice.
Not available
S-EPMC5983903 | biostudies-literature
UnknownLebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study.
Not available
S-EPMC12936214 | biostudies-literature
UnknownHuman iPSC-Derived Cerebral Organoids Model Cellular Features of Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia.
Not available
S-EPMC5667944 | biostudies-literature
UnknownLY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase.
Not available
S-EPMC5843917 | biostudies-literature
UnknownPharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor.
Not available
S-EPMC3828007 | biostudies-literature
UnknownSerotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience.
Not available
S-EPMC10641788 | biostudies-literature
UnknownEvaluating the association of apolipoprotein E genotype and cognitive resilience in SuperAgers.
Not available
S-EPMC12809718 | biostudies-literature
Sort   by:  
 Page size